Medic Specialist Dermatovenerologie & Doctor în Științe Medicale
2025-prezent: Medic specialist dermatovenerologie
2021-prezent: Cadru didactiv asociat Universitatea de Medicină și Farmacie „Iuliu Hațieganu” Cluj-Napoca
2020-2025: Medic rezident Dermatovenerologie, Spitalul Clinic de Boli Infecțioase
2023-2024: Study investigator ARGX-113-2009 A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
2023-2024: Study investigator ANB019-301: A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Adult Subjects with Generalized Pustular Psoriasis
2023-2024: Study investigator „A randomized, Double-Blind, Placebo-Controlled, Multiple Rising Dose Clinical Trial to Investigate Safety, Tolerability, pharmacokinetics of MK-6194 in Participants with Moderate to Severe Atopic Dermatitis”
2023-prezent: Study investigator „Safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous and subcutaneous multiple rising doses of BI 765250 versus placebo in trial participants with moderate to severe plaque psoriasis
2022-2024: Study investigator ARGX-113-1904 A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Pemphigus
2022-2024: Study investigator ARGX-113-1905 A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Pemphigus
2017-2018: Imagistic student workshop
2015-2016: General surgery student workshop
2015-2016: Vascular surgery student workshop
2016: Winner of the „MedChallenge” Semiology Contest – Organization of Medical Students Cluj-Napoca
Conectează-te cu specialiștii Clinicii Medispa și găsește soluțiile și tratamentele perfecte pentru tine.